Development and Evaluation of a Self-Management Model for Cancer Rehabilitation

After the intervention period for the patients, the change in the HADS (Hospital Anxiety and Depression Scale) total score was assessed based on the scoring criteria, comparing the scores to the baseline.

The HADS scoring ranges are as follows:

Total Score Range: 0 to 42； Anxiety Subscale (HADS-A): 0 to 21； Depression Subscale (HADS-D): 0 to 21；

Score Interpretation:

0-7: Normal range, typically indicating no significant anxiety or depression symptoms.； 8-10: Mild anxiety or depression, may warrant monitoring; 11-14: Moderate anxiety or depression, further assessment or intervention is advisable; 15 and above: Severe anxiety or depression, usually requiring professional mental health intervention; In summary, higher scores on the HADS indicate more severe symptoms of anxiety or depression.

The QLQ-C30 (European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30) is a tool designed to assess the quality of life in cancer patients. It consists of 30 items covering various dimensions of quality of life, including functional status, symptoms, and overall health status.

Score Range:

Functional Status:

Maximum Score: 100 Minimum Score: 0.

Symptoms:

Maximum Score: 100 (note: higher scores indicate worse symptoms) Minimum Score: 0.

Overall Health Status:

Maximum Score: 100 Minimum Score: 0.

Evaluating Treatment Effects: Comparing scores before and after treatment to assess the impact on quality of life.

Clinical Research: As a standard tool for assessing quality of life in cancer studies.

Patient Management: Helping healthcare providers identify specific patient needs to optimize treatment plans.

Anxiety and Depression: Assessed at baseline (before intervention), every two weeks during the intervention period, and every four weeks during the follow-up period, according to the scoring criteria of the HADS.

Score Range Maximum Score: Each subscale has a maximum score of 21 (7 items × 3 points each).

Minimum Score: Each subscale has a minimum score of 0 (indicating no symptoms).

Supportive Care Needs Level: Evaluated at baseline (before intervention), every two weeks during the intervention period, and every four weeks during the follow-up period, using the scoring criteria of the Supportive Care Needs Survey (SCNS-SF34).

Scoring Method: Each item is typically rated on a 4-point Likert scale (1 = no need, 2 = low need, 3 = moderate need, 4 = high need).

Total Score Range:Minimum Score: 34 (if every item is scored as 1)；Maximum Score: 136 (if every item is scored as 4)。 Score Significance 34-68: Low Need; Indicates that the patient has minimal supportive care needs. 69-102: Moderate Need; Suggests that the patient has some areas where additional support or resources may be beneficial.

103-136: High Need; Reflects significant supportive care needs across multiple domains, indicating that the patient may require urgent intervention and comprehensive support.

Peripheral venous blood samples were collected from enrolled patients at baseline and at weeks 0, 4, 8, and 12 after intervention. The stress biomarkers tested include the concentrations of adrenaline, norepinephrine, cortisol, and adrenocorticotropic hormone. The patient needs to lie on their back for 15 minutes before blood collection, and must avoid drinking alcohol, coffee, and smoking for 12 hours before blood collection. After collection, the blood sample should be immediately sent to the laboratory for analysis.